GLP-1 weight loss

Nexlife

Checked October 15, 2026 2 sources nexlife.us ↗

Nexlife is a telehealth weight-loss platform whose independent providers may prescribe compounded GLP-1s.

What it is

Subscription includes provider consults, prescription management and progress-tracking tools.

Only compounded semaglutide and tirzepatide are offered; site says they are not FDA-approved.

Prescribes: Compounded semaglutide and tirzepatide

What it costs

Compounded semaglutide, monthly	from $1392
Compounded tirzepatide, monthly	from $1692

Insurance: Not stated on site

Prices change often. Check nexlife.us before you sign up.

Pros and cons

Pros

Cons

Cancellation requires 30 days' notice per site2

Records we found

Official and court records we found in public sources as of October 15, 2026. This is not a live or complete record; check fda.gov, ftc.gov and court sites for the latest.

Jun 2026
FDA
FDA sent a warning letter stating that labels naming Nexlife implied it was the compounder, rendering the products misbranded under sections 502(a) and 502(bb) of the FD&C Act.1

Sources

Emerge Care is not affiliated with Nexlife and earns nothing if you use it. Nexlife and its logo are trademarks of their owner, used only to identify it. This page lists public facts with sources and is not medical advice or a recommendation. Spotted something wrong or out of date? Email hello@getemergeapp.com and we will fix it.